Very early researchWithdrawnNCT02695641
What this trial is testing
Reduction of Plasma Free VEGF-A Using Low-dose Bevacizumab in Hemodialysis Patients
Who this might be right for
End Stage Renal DiseaseHemodialysis Vascular Access Failure
Mayo Clinic